TEVA PHARM FIN CO LLC Teva Pharmaceutical Finance Co LLC is a security (CUSIP 88163VAD1) tracked across SEC portfolio filings. 11 registered fund positions totaling $16.3M via N-PORT as of 2026-05-31.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| DoubleLine Core Fixed Income Fund | DoubleLine Funds Trust | $5.2M | 7.54% |
| Bond Fund | John Hancock Sovereign Bond Fund | $4.4M | 1.65% |
| Loomis Sayles Global Allocation Fund | LOOMIS SAYLES FUNDS II | $2.8M | 10.70% |
| Western Asset Diversified Income Fund | Western Asset Diversified Income Fund | $2.1M | 28.12% |
| THRIVENT CORE HIGH YIELD BOND FUND | Thrivent Core Funds | $524K | 5.76% |
| Western Asset High Yield Fund | Western Asset Funds Inc | $411K | 18.69% |
| Transamerica Janus Balanced VP | TRANSAMERICA SERIES TRUST | $320K | 4.18% |
| RiverNorth/DoubleLine Strategic Income Fund | RIVERNORTH FUNDS | $237K | 2.37% |
| Emerging Markets Core Fund | Federated Hermes Core Trust | $210K | 2.61% |
| New America High Income Fund Inc | NEW AMERICA HIGH INCOME FUND INC | $154K | 7.96% |
| John Hancock Income Securities Trust | John Hancock Income Securities Trust | $38K | 2.65% |